天演药业赴美IPO在即，高盛、摩根士丹利等知名投行共同助力

时刻头条2021-02-04

1月20日，临床阶段生物药企天演药业（苏州）有限公司（下称“天演药业”）向美国SEC递交招股书，拟以“ADAG”为交易代码，于2月9日在纳斯达克正式挂牌上市。本次天演药业IPO，联席承销商包括高盛、摩根士丹利、杰富瑞、华兴资本等知名投行。值得注意的是，除本次极为豪华的承销商阵容外，天演药业在前数轮融资中已获金浦健康投资、斯道资本、F-Prime Capital、药明康德(行情603259)及泛...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2108715598?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/c4a03a5ae5cfc1aad727ce9e6d2b27bb","is_english":false,"pubTime":"2021-02-04 16:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2108715598","market":"us","top_or_hot":-1,"title":"天演药业赴美IPO在即，高盛、摩根士丹利等知名投行共同助力","media":"时刻头条","content":"<div>\n<p>1月20日，临床阶段生物药企天演药业（苏州）有限公司（下称“天演药业”）向美国SEC递交招股书，拟以“ADAG”为交易代码，于2月9日在纳斯达克正式挂牌上市。本次天演药业IPO，联席承销商包括高盛、摩根士丹利、杰富瑞、华兴资本等知名投行。值得注意的是，除本次极为豪华的承销商阵容外，天演药业在前数轮融资中已获金浦健康投资、斯道资本、F-Prime Capital、药明康德(行情603259)及泛...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210204164500798cc431&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>天演药业赴美IPO在即，高盛、摩根士丹利等知名投行共同助力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n天演药业赴美IPO在即，高盛、摩根士丹利等知名投行共同助力\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-04 16:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210204164500798cc431&s=b><strong>时刻头条</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1月20日，临床阶段生物药企天演药业（苏州）有限公司（下称“天演药业”）向美国SEC递交招股书，拟以“ADAG”为交易代码，于2月9日在纳斯达克正式挂牌上市。本次天演药业IPO，联席承销商包括高盛、摩根士丹利、杰富瑞、华兴资本等知名投行。值得注意的是，除本次极为豪华的承销商阵容外，天演药业在前数轮融资中已获金浦健康投资、斯道资本、F-Prime Capital、药明康德(行情603259)及泛...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210204164500798cc431&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MS","symbol_name":"摩根士丹利","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210204164500798cc431&s=b","article_id":"2108715598","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/c4a03a5ae5cfc1aad727ce9e6d2b27bb"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210204164500798cc431&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2108715598","pubTimestamp":1612427825,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"本次天演药业IPO，此次联席承销商高盛、摩根士丹利、杰富瑞、华兴资本等知名投行一道，助力天演药业的IPO认购，以成功冲刺纳斯达克。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"MS":"摩根士丹利","ADAG":"天演药业","FUTU":"富途控股","GS":"高盛"},"translate_title":"Tianyan Pharmaceutical's IPO in the United States is just around the corner, and well-known investment banks such as Goldman Sachs and Morgan Stanley will help together","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADAG":0.9,"FHL":0.9,"FUTU":0.9,"GS":0.9,"MS":0.9},"content_text":"1月20日，临床阶段生物药企天演药业（苏州）有限公司（下称“天演药业”）向美国SEC递交招股书，拟以“ADAG”为交易代码，于2月9日在纳斯达克正式挂牌上市。本次天演药业IPO，联席承销商包括高盛、摩根士丹利、杰富瑞、华兴资本等知名投行。值得注意的是，除本次极为豪华的承销商阵容外，天演药业在前数轮融资中已获金浦健康投资、斯道资本、F-Prime Capital、药明康德(行情603259)及泛大西洋(行情600558)投资等投资方的资金加持，以上投资方在发行前持股比例均超10%。天演药业创办于2012年，其创始人兼CEO罗培志博士是一位生物医药领域的连续创业者，曾于2000年联合创立了Abmaxis，为创新药开发提供抗体相关技术服务。天演药业致力于开发新一代治疗性和诊断用抗体技术，已建立拥有自主知识产权的抗体研发平台——动态精准抗体库（DPL），基于人工智能、计算生物学、生物信息及基因工程技术的自主研发背景，深度布局肿瘤免疫及靶向治疗药物的开发。该平台由AI技术驱动，它所产生的先导抗体同时具备优异的生物学功能与成药性，可大幅提高抗体药物发现的效率。天演药业研发的核心管线包括ADG106、ADG116和ADG126。其中，ADG106的靶点及作用机制为全球首创，已在美国和中国同时进行临床试验，有望最快实现商业化。近年来，全球医疗健康产业正在不断跨界，融合人工智能、物联网、大数据、5G等高科技技术，奏响“智慧医疗”的主旋律。在过去的2020年，创新生物医药行业得到了前所未有的政策、资金支持和飞跃式发展，投融资形势更是持续升温——恒瑞医疗、迈瑞医疗(行情300760)、药明康德等中国生物医药龙头企业市值均超过3000亿元。此外，根据中商产业研究院数据显示，2021年中国生物医药市场规模将进一步扩大至4644亿元。天演药业身处中国创新医药赛道，则瞄准了市场抗体这一增长迅速的刚需领域，凭借自主研发的核心技术优势，形成了在抗体服务市场的坚固壁垒。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2108715598"}